|
IDI1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.62012633811537E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.88338275267597E-15 |
| Normal-vs-Stage2 |
1.63069557856943E-12 |
| Normal-vs-Stage3 |
3.66373598126302E-14 |
| Normal-vs-Stage4 |
5.75270000524597E-08 |
| Stage1-vs-Stage2 |
7.034400E-01 |
| Stage1-vs-Stage3 |
1.550620E-01 |
| Stage1-vs-Stage4 |
1.140960E-01 |
| Stage2-vs-Stage3 |
5.027600E-01 |
| Stage2-vs-Stage4 |
2.686400E-01 |
| Stage3-vs-Stage4 |
6.634400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63813407283442E-12 |
| Normal-vs-AfricanAmerican |
4.66293670342566E-15 |
| Normal-vs-Asian |
2.41970000000036E-05 |
| Caucasian-vs-AfricanAmerican |
9.228200E-01 |
| Caucasian-vs-Asian |
2.555200E-01 |
| AfricanAmerican-vs-Asian |
2.353800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.43689570931383E-15 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.040300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62625468647093E-12 |
| Normal-vs-Extreme_Weight |
2.55351295663786E-15 |
| Normal-vs-Obese |
1.63535851527286E-12 |
| Normal-vs-Extreme_Obese |
1.73949998849565E-09 |
| Normal_Weight-vs-Extreme_Weight |
4.315600E-01 |
| Normal_Weight-vs-Obese |
7.938000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.050400E-01 |
| Extreme_Weight-vs-Obese |
1.468590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.752600E-01 |
| Obese-vs-Extreme_Obese |
3.808400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.91748872125208E-14 |
| Normal-vs-Age(41-60Yrs) |
1.63824509513688E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63136171238421E-12 |
| Normal-vs-Age(81-100Yrs) |
4.44089209850063E-16 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.841000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.946200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.025600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.829200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.272000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.347900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.88258347483861E-15 |
| Normal-VS-Type2 PRCC |
1.58761892521397E-14 |
| Normal-VS-KIRP CIMP |
2.87290000011708E-07 |
| Normal-VS-Unclassified PRCC |
1.66533453693773E-15 |
| Type1 PRCC-VS-Type2 PRCC |
1.329740E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.083600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.021200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.564000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.410400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.414400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
6.66577903984944E-13 |
| Normal-vs-N2 |
2.154200E-04 |
| N0-vs-N1 |
9.986200E-02 |
| N0-vs-N2 |
7.786400E-01 |
| N1-vs-N2 |
8.679200E-01 |
|
|
